India's law contains elements that help put people before patents, but Novartis is taking the Indian government to court to force a change in the law.
If Novartis is successful in its challenge against the Indian government and its patent law, more medicines are likely to be patented in India, making it very difficult for generic producers to make affordable versions of them. This could affect millions of people around the world who depend on medicines produced in India.
Tell Novartis it has no business standing in the way of people's right to access the medicines they need. Sign on and urge Novartis to DROP THE CASE against the Indian government.
http://www.msf.org/petition_india/international.html